Webinar: Maximizing the effectiveness and safety of CBD dominant phytocannabinoid therapies

Basil Shaaban, Co-founder and Head of Science at Cannacea
Sasha Kalcheff-Korn, Executive Director at RoC

Having researched and developed phytocannabinoid therapies since the year 2000, in 2016 the founders of Cannacea revolutionized the health of their Mother, Tagrid, with her early-onset Alzheimer’s Disease and Psychosis, by creating specialized full spectrum hemp oil formulations with lowered relative THC levels, alongside key guidance from the Realm of Caring. After witnessing hemp’s immense therapeutic power with their matriarch, they were compelled to share their unique hemp oil formulas with the World and founded Cannacea in 2017. Cannacea has since become a hemp pioneer with their clinical organic hemp oils including “Tagrid’s 100”, industry-leading lab testing scopes, and in-depth cannabinoid science education for practitioners, all founded upon Cannacea’s lab-certified “complete hemp full spectrum” phytochemistry for maximum efficacy, safety, and biocompatibility.

Visit Cannacea at: https://cannacea.life/